Literature DB >> 20576914

Interpopulation variation in HIV testing promptness may introduce bias in HIV incidence estimates using the serologic testing algorithm for recent HIV seroconversion.

Edward White1, Gary Goldbaum, Steven Goodreau, Thomas Lumley, Stephen E Hawes.   

Abstract

OBJECTIVES: The serologic testing algorithm for recent HIV seroconversion (STARHS) calculates incidence using the proportion of testers who produce a level of HIV antibody high enough to be detected by ELISA but low enough to suggest recent infection. The validity of STARHS relies on independence between dates of HIV infection and dates of antibody testing. When subjects choose the time of their own test, testing may be motivated by risky behaviour or symptoms of infection and the criterion may not be met. This analysis was conducted to ascertain whether estimates of incidence derived using STARHS were consistent with estimates derived using a method more robust against motivated testing.
METHODS: A cohort-based incidence estimator and two STARHS methods were applied to identical populations (n=3821) tested for HIV antibody at publicly funded sites in Seattle. Overall seroincidence estimates, demographically stratified estimates and incidence rate ratios were compared across methods. The proportion of low-antibody testers among HIV-infected individuals was compared with the proportion expected given their testing histories.
RESULTS: STARHS estimates generally exceeded cohort-based estimates. Incidence ratios derived using STARHS between demographic strata were not consistent across methods. The proportion of HIV-infected individuals with lower antibody levels exceeded that which would be expected under independence between infection and testing.
CONCLUSIONS: Incidence estimates and incidence rate ratios derived using methods that rely on the changing antibody level over the course of HIV infection may be vulnerable to bias when applied to populations who choose the time of their own testing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576914      PMCID: PMC3414255          DOI: 10.1136/sti.2009.037291

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  18 in total

1.  HIV in the United States at the turn of the century: an epidemic in transition.

Authors:  J M Karon; P L Fleming; R W Steketee; K M De Cock
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

2.  Estimation of human immunodeficiency virus (HIV) seroincidence among repeat anonymous testers in San Francisco.

Authors:  W McFarland; T A Kellogg; J Dilley; M H Katz
Journal:  Am J Epidemiol       Date:  1997-10-15       Impact factor: 4.897

3.  Changes in condom use among homosexual men in San Francisco.

Authors:  J A Catania; T J Coates; R Stall; L Bye; S M Kegeles; F Capell; J Henne; L McKusick; S Morin; H Turner
Journal:  Health Psychol       Date:  1991       Impact factor: 4.267

4.  Validating marker-based incidence estimates in repeatedly screened populations.

Authors:  G A Satten; R Janssen; M P Busch; S Datta
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

Review 5.  The current status of methods for estimating the prevalence of human immunodeficiency virus in the United States of America.

Authors:  J M Karon; M Khare; P S Rosenberg
Journal:  Stat Med       Date:  1998-01-30       Impact factor: 2.373

6.  Symptomatic primary HIV infection or risk experiences? Circumstances surrounding HIV testing and diagnosis among recent seroconverters.

Authors:  Ann N Burchell; Liviana Calzavara; Nancy Ramuscak; Ted Myers; Carol Major; Anita Rachlis; Kevin Gough; Janet Raboud; Robert S Remis
Journal:  Int J STD AIDS       Date:  2003-09       Impact factor: 1.359

7.  HIV seroincidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996. STD Clinic HIV Seroincidence Study Group.

Authors:  H Weinstock; S Sweeney; G A Satten; M Gwinn
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-12-15

8.  HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand.

Authors:  D Kitayaporn; C Uneklabh; B G Weniger; P Lohsomboon; J Kaewkungwal; W M Morgan; T Uneklabh
Journal:  AIDS       Date:  1994-10       Impact factor: 4.177

9.  When patients first suspect and find out they are infected with the human immunodeficiency virus: implications for prevention.

Authors:  N S Wenger; F S Kusseling; K Beck; M F Shapiro
Journal:  AIDS Care       Date:  1994

10.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

View more
  4 in total

1.  Individualized diagnosis interventions can add significant effectiveness in reducing human immunodeficiency virus incidence among men who have sex with men: insights from Southern California.

Authors:  Aditya Khanna; Steven M Goodreau; Dan Wohlfeiler; Eric Daar; Susan Little; Pamina M Gorbach
Journal:  Ann Epidemiol       Date:  2014-10-07       Impact factor: 3.797

2.  Stochastic models to demonstrate the effect of motivated testing on HIV incidence estimates using the serological testing algorithm for recent HIV seroconversion (STARHS).

Authors:  Edward W White; Thomas Lumley; Steven M Goodreau; Gary Goldbaum; Stephen E Hawes
Journal:  Sex Transm Infect       Date:  2010-11-08       Impact factor: 3.519

3.  High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland.

Authors:  Magdalena Rosińska; Anna Marzec-Bogustawska; Janusz Janiec; Joanna Smoleń-Dzirba; Tomasz Wąsik; Joanna Gniewosz; Małgorzata Zalewska; Gary Murphy; Elaine McKinney; Kholoud Porter
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-26       Impact factor: 2.205

4.  Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France.

Authors:  Stéphane Le Vu; Annie Velter; Laurence Meyer; Gilles Peytavin; Jérôme Guinard; Josiane Pillonel; Francis Barin; Caroline Semaille
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.